RowdMap, Inc. Chief Scientific Officer, Joshua Rosenthal, PhD, featured on Public Interest Podcast on Social Mandate for High-Value Healthcare
Joshua Rosenthal, PhD, joins President of National Committee on Quality Assurance, Senators, Pulitzer Prize Winners, Ambassadors, Nobel Peace Prize Winners, the Deputy Secretary of the Treasury and Hospital and Health Plan CEOs on Public Interest Podcast Discussing Public Good and Financial Impact of High-Value Care
LOUISVILLE, Ky., March 24, 2017 /PRNewswire/ -- Joshua Rosenthal, PhD, of RowdMap, Inc. joins President of National Committee on Quality Assurance (NCQA), Senators, Pulitzer Prize Winners, Ambassadors, Nobel Peace Prize Winners, the Deputy Secretary of the Treasury and Hospital and Health Plan CEO's on the Public Interest Podcast, a program that consists of conversations with politicians, activists, advocates, and others who seek to improve the world. http://bit.ly/publicinterestRowdMap
The conversation centers on the use of big data to produce a public good, all while creating market value for healthcare payers and providers. Meaning that the transition to high-value care is not only a fiscal sustainability issue, it is also a driver of social good. In the past, with fee-for-service, there were no financial incentives for providers to practice high-value care. With the continuing shift towards pay-for-value policies, there is now both financial and social incentive to practice high-value care. Joshua Rosenthal continues by highlighting that RowdMap, Inc is achieving public and social good through the marketplace, rather than through a non-profit, which is what most would assume is necessary. Creating financial value for payers, providers, and consumers is essential in creating this public good.
"Historically we have done a disservice to the health and finances of people by perversely incentivizing low-value care. Fortunately, both payers and providers are adopting high-value care, which benefits health plans, physicians, and consumers. High-value care has moved from an academic subject in journals to a core strategic driver of real world delivery," said Joshua Rosenthal, PhD, Chief Scientific Officer, RowdMap, Inc.
The podcast continues to expand on the theme of high-value care and how it impacts the population as a whole. 6% of the Gross Domestic Product (GDP) goes to low-value care, that is, procedures, prescriptions, and other care that is higher intensity with no better clinical outcome. If the 6% of GDP that goes to low-value care is eliminated, there is more than enough healthcare for everyone in the country, as well as keeps more money in the average American's pocket, money that can be spent on food, shelter, and education.
About RowdMap:
An Ernst and Young EY Entrepreneur Of The Year® winner, RowdMap's Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce no-value care that physicians deliver- a central tenet of successful pay-for-value programs.
Through practice patterns and referral analysis, RowdMap's benchmarks identify the health care entities that manage unwarranted and unexpected variation in care. This variation leads to more than $850 Billion in no-value care annually. Payers and physicians use RowdMap's physician and population health benchmarks to create strategies that put these highest performing physicians at the center of networks and then design products, organize clinical programs, and coordinate sales and marketing around them.
RowdMap's platform comes preloaded with benchmarks for every physician, hospital, and zip code in the United States- no IT integration required. RowdMap's Risk-Readiness® Platform works across all market segments and has significantly larger returns than traditional medical economics approaches.
Contact: Josh Rosenthal, [email protected]
SOURCE RowdMap, Inc.
Share this article